Literature DB >> 17275169

Resurfacing and reconstruction of the glans penis.

Enzo Palminteri1, Elisa Berdondini, Massimo Lazzeri, Francesco Mirri, Guido Barbagli.   

Abstract

OBJECTIVES: To describe the techniques and results of surgical reconstruction of glans penis lesions.
METHODS: Seventeen patients (mean age: 53.2 yr) were treated by resurfacing or reconstruction of the glans penis for benign, premalignant and malignant penile lesions. The aetiology of the lesions was one Zoon's balanitis, four lichen sclerosus, one carcinoma in situ, five squamous cell carcinomas, and six squamous cell carcinomas associated with lichen sclerosus. Five cases were treated by glans skinning and resurfacing; five cases by glans amputation and reconstruction of the neoglans, and seven cases by partial penile amputation and reconstruction of the neoglans. Glans resurfacing and reconstruction were performed with the use of a skin graft harvested from the thigh.
RESULTS: The mean follow-up was 32 mo. All patients were free of local premalignant/malignant recurrence. Patients who underwent glans resurfacing reported glandular sensory restoration and complete sexual ability. Patients who underwent glansectomy or partial penectomy with neoglans reconstruction maintained sexual function and activity, although sensitivity was reduced as a consequence of glans/penile amputation.
CONCLUSIONS: In selected cases of benign, premalignant or malignant penile lesions, glans resurfacing or reconstruction can ensure a normal appearing and functional penis, without jeopardizing cancer control. European Association of Urology.

Entities:  

Mesh:

Year:  2007        PMID: 17275169     DOI: 10.1016/j.eururo.2007.01.047

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  28 in total

1.  Sexual function after surgical treatment for penile cancer: Which organ-sparing approach gives the best results?

Authors:  Omid Sedigh; Marco Falcone; Carlo Ceruti; Massimiliano Timpano; Mirko Preto; Marco Oderda; Franklin Kuehhas; Mattia Sibona; Arianna Gillo; Paolo Gontero; Luigi Rolle; Bruno Frea
Journal:  Can Urol Assoc J       Date:  2015 Jul-Aug       Impact factor: 1.862

Review 2.  [Organ-sparing surgery for penile cancer].

Authors:  B Schlenker; C Gratzke; D Tilki; E Hungerhuber; P Schneede; O Reich; C G Stief; M Seitz
Journal:  Urologe A       Date:  2008-07       Impact factor: 0.639

3.  Surgical treatment of primary disease for penile squamous cell carcinoma: A Surveillance, Epidemiology, and End Results database analysis.

Authors:  Yao Zhu; Wei-Jie Gu; Hong-Kai Wang; Cheng-Yuan Gu; Ding-Wei Ye
Journal:  Oncol Lett       Date:  2015-05-18       Impact factor: 2.967

Review 4.  Penile preserving and reconstructive surgery in the management of penile cancer.

Authors:  Arthur L Burnett
Journal:  Nat Rev Urol       Date:  2016-03-22       Impact factor: 14.432

Review 5.  Challenges and controversies in the management of penile cancer.

Authors:  Majid Shabbir; Oliver Kayes; Suks Minhas
Journal:  Nat Rev Urol       Date:  2014-11-18       Impact factor: 14.432

Review 6.  [Lichen sclerosus in the genitourinary region].

Authors:  C Hofer; F-M Köhn; G S Hatzichristodoulou; J E Gschwend; U Treiber
Journal:  Urologe A       Date:  2011-10       Impact factor: 0.639

Review 7.  [Reconstructive surgery in penile cancer].

Authors:  M Sohn; M Dietrich; A Wirthmann; U M Rieger
Journal:  Urologe A       Date:  2018-04       Impact factor: 0.639

Review 8.  Organ Preservation Surgery for Carcinoma Penis.

Authors:  T B Yuvaraja; Santosh Waigankar; Nikhil Dharmadhikari; Abhinav Pednekar
Journal:  Indian J Surg Oncol       Date:  2016-12-20

9.  [Excision of carcinoma in situ of the glans penis with reconstructive plastic surgery].

Authors:  M Angerer-Shpilenya; N T Gaisa; G Jakse
Journal:  Urologe A       Date:  2010-03       Impact factor: 0.639

Review 10.  Review of penile reconstructive techniques.

Authors:  Sverrir Kristinsson; Mark Johnson; David Ralph
Journal:  Int J Impot Res       Date:  2020-03-09       Impact factor: 2.896

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.